111 related articles for article (PubMed ID: 9618849)
21. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
Pandya PP; Kondylios A; Hilbert L; Snijders RJ; Nicolaides KH
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):15-9. PubMed ID: 7850583
[TBL] [Abstract][Full Text] [Related]
22. Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency.
Hafner E; Schuchter K; Philipp K
Ultrasound Obstet Gynecol; 1995 Nov; 6(5):330-3. PubMed ID: 8590203
[TBL] [Abstract][Full Text] [Related]
23. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
[TBL] [Abstract][Full Text] [Related]
24. First trimester sonographic detection of chromosomal abnormalities in an unselected population.
Economides DL; Whitlow BJ; Kadir R; Lazanakis M; Verdin SM
Br J Obstet Gynaecol; 1998 Jan; 105(1):58-62. PubMed ID: 9442163
[TBL] [Abstract][Full Text] [Related]
25. First-trimester nuchal translucency: a risk analysis on fetal chromosome abnormality.
van Vugt JM; van Zalen-Sprock RM; Kostense PJ
Radiology; 1996 Aug; 200(2):537-40. PubMed ID: 8685353
[TBL] [Abstract][Full Text] [Related]
26. Nuchal translucency in fetuses affected by homozygous alpha-thalassemia-1 at 12-13 weeks of gestation.
Lam YH; Tang MH; Lee CP; Tse HY
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):238-40. PubMed ID: 10341400
[TBL] [Abstract][Full Text] [Related]
27. Three- versus two-dimensional ultrasound for nuchal translucency thickness measurements: comparison of feasibility and levels of agreement.
Eppel W; Worda C; Frigo P; Lee A
Prenat Diagn; 2001 Jul; 21(7):596-601. PubMed ID: 11494299
[TBL] [Abstract][Full Text] [Related]
28. Nuchal translucency measurement in normal fetuses.
Pajkrt E; Bilardo CM; Van Lith JM; Mol BW; Bleker OP
Obstet Gynecol; 1995 Dec; 86(6):994-7. PubMed ID: 7501355
[TBL] [Abstract][Full Text] [Related]
29. First-trimester increased nuchal translucency and fetal hypokinesia associated with Zellweger syndrome.
Johnson JM; Babul-Hirji R; Chitayat D
Ultrasound Obstet Gynecol; 2001 Apr; 17(4):344-6. PubMed ID: 11339194
[TBL] [Abstract][Full Text] [Related]
30. [Ultrasound fetal nuchal translucency screening at 12-13 weeks of gestation. More effective method of selection for amniocentesis than the maternal age].
Persson PH; Robertz AM; Weldner BM
Lakartidningen; 2003 May; 100(20):1799-805. PubMed ID: 12806860
[No Abstract] [Full Text] [Related]
31. Increased nuchal translucency thickness at 10-14 weeks of gestation as a predictor of severe twin-to-twin transfusion syndrome.
Sebire NJ; D'Ercole C; Hughes K; Carvalho M; Nicolaides KH
Ultrasound Obstet Gynecol; 1997 Aug; 10(2):86-9. PubMed ID: 9286014
[TBL] [Abstract][Full Text] [Related]
32. Fetal chromosomal abnormalities: antenatal screening and diagnosis.
Anderson CL; Brown CE
Am Fam Physician; 2009 Jan; 79(2):117-23. PubMed ID: 19178062
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age.
Theodoropoulos P; Lolis D; Papageorgiou C; Papaioannou S; Plachouras N; Makrydimas G
Prenat Diagn; 1998 Feb; 18(2):133-7. PubMed ID: 9516014
[TBL] [Abstract][Full Text] [Related]
34. Predictive value of fetal nuchal translucency.
Loncar D
Med Glas (Zenica); 2011 Feb; 8(1):19-23. PubMed ID: 21263390
[TBL] [Abstract][Full Text] [Related]
35. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
[TBL] [Abstract][Full Text] [Related]
36. Comparison between two methods of standardization for gestational age differences in fetal nuchal translucency measurement in first-trimester screening for trisomy 21.
Biagiotti R; Periti E; Brizzi L; Vanzi E; Cariati E
Ultrasound Obstet Gynecol; 1997 Apr; 9(4):248-52. PubMed ID: 9168573
[TBL] [Abstract][Full Text] [Related]
37. [Screening for Down's syndrome at week 10-14 by measuring fetal nuchal translucency thickness].
Maymon R; Dreazen E; Weinraub Z; Bukovsky I; Herman A
Harefuah; 1999 Nov; 137(9):353-7, 432. PubMed ID: 11419032
[TBL] [Abstract][Full Text] [Related]
38. Three-dimensional transvaginal ultrasound improves measurement of nuchal translucency.
Kurjak A; Kupesic S; Ivancić-Kosuta M
J Perinat Med; 1999; 27(2):97-102. PubMed ID: 10379497
[TBL] [Abstract][Full Text] [Related]
39. Nuchal fold thickness at 14-16 weeks' gestation as measured by transvaginal sonography.
Ben-Ami M; Perlitz Y; Mukary M; Peleg D
Ultrasound Obstet Gynecol; 2002 Jan; 19(1):60-1. PubMed ID: 11851970
[TBL] [Abstract][Full Text] [Related]
40. Fetal heart rate in trisomy 21 and other chromosomal abnormalities at 10-14 weeks of gestation.
Hyett JA; Noble PL; Snijders RJ; Montenegro N; Nicolaides KH
Ultrasound Obstet Gynecol; 1996 Apr; 7(4):239-44. PubMed ID: 8726874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
